Carboplatin-paclitaxel becomes better option for treatment of inoperable anal cancer: Study
A new study has suggested that people with inoperable anal cancer treated with carboplatin-paclitaxel had fewer complications and lived longer than those who received another chemotherapy that has been more often administered.
Jun 26, 2020, 15:21 PM IST
Socio-economic status may affect patients with anal cancer
According to the researchers, squamous cell carcinoma of the anus (SCCA) accounts for 8,200 new cancer cases and more than 1,000 cancer-related deaths in the US annually.
